GLUE Stock Analysis: Buy, Sell, or Hold?
GLUE - Monte Rosa Therapeutics, Inc. Common Stock
$18.15
-0.53 (-2.84%)
▼
5d:
-6.4%
30d:
-2.94%
90d:
+1.28%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Smart Money Accumulation
GLUE is down 6.4% this week, but smart money is accumulating calls. Top strike: $22.5 2026-06-18 with 1,003 OI. Call ratio: 100% View Scanner →
Strength: 8.2/10
Get Alerted When GLUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GLUE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GLUE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GLUE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GLUE is currently trading at $18.15, which is considered extended relative to its 30-day fair value range of $17.71 to $20.20.
Technical Outlook: Technically, GLUE is in a downtrend. The price is currently testing key support at $17.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.33 (+78.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GLUE is in a downtrend. The price is currently testing key support at $17.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.33 (+78.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.71 -
$20.20
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
Protect Your Profits
Holding GLUE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.1% below Wall St target ($32.33)
- CAUTION: 5-day price weakness (-6.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$17.71 -
$20.20
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.93
Resistance Level
$21.27
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.32
Wall Street Target
$32.33
(+78.1%)
Revenue Growth (YoY)
-95.0%
Share & Embed Analysis
Last updated: May 18, 2026 8:26 AM ET
Data refreshes hourly during market hours. Next update: 9:26 AM
Data refreshes hourly during market hours. Next update: 9:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Philip Nickson
SELL
5845 shares
2026-04-09
Edmund Dunn
SELL
139 shares
2026-03-04
Edmund Dunn
SELL
536 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
Advanced GLUE Option Strategies
Professional options setups generated by AI based on today's GLUE price and gamma walls.
